Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

Title
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 68, Issue 12, Pages 1863-1869
Publisher
BMJ
Online
2009-01-16
DOI
10.1136/ard.2008.102103

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started